| DBORX | RLBAX | DBORX / RLBAX | |
| Total Expense Ratio | 0.90 | 1.32 | 68% |
| Annual Report Gross Expense Ratio | 1.01 | 1.32 | 77% |
| Fund Existence | 23 years | 24 years | - |
| Gain YTD | 6.593 | 9.204 | 72% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 250 | 400% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 292M | 283B | 0% |
| Annual Yield % from dividends | 1.35 | 1.12 | 121% |
| Returns for 1 year | 3.63 | 9.51 | 38% |
| Returns for 3 years | 21.31 | 39.71 | 54% |
| Returns for 5 years | -2.43 | 27.42 | -9% |
| Returns for 10 years | 32.59 | 73.44 | 44% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ROKT | 108.82 | 0.31 | +0.28% |
| Stt Strt® SPDR® S&PKenshoFnlFrntrsETF | |||
| VCLT | 71.62 | 0.08 | +0.11% |
| Vanguard Long-Term Corporate Bd ETF | |||
| TDSB | 25.00 | -0.05 | -0.19% |
| ETC Cabana Target Beta ETF | |||
| HQL | 20.64 | -0.07 | -0.34% |
| abrdn Life Sciences Investors | |||
| ORCS | 26.91 | -0.82 | -2.96% |
| Direxion Daily ORCL Bear 1X ETF | |||